Navigation Links
Proposed Bill to Protect Patient Access to Osteoporosis Testing by Reversing Cuts in Medicare Reimbursement
Date:11/26/2007

Study finds reimbursement for DXA test will save Medicare $1.14 billion over five years

WASHINGTON, Nov. 26 /PRNewswire-USNewswire/ -- In an effort to protect patient access to osteoporosis testing and reduce the physical and economic burden of osteoporosis for millions of Americans, Congress introduced H.R. 4206 "Medicare Fracture Prevention and Osteoporosis Testing Act of 2007," sponsored by Congresswoman Shelley Berkley (D-1st-NV) and supported by 41 original cosponsors. The bill calls for the reversal of drastic cuts in Medicare reimbursement for Dual Energy X-ray Absorptiometry, DXA, the imaging procedure accepted as the gold standard for diagnosing osteoporosis. This legislation builds on federal initiatives already in place to increase fracture prevention efforts and improve the prevention, detection and treatment of osteoporosis.

Medicare reimbursement for DXA has been cut to levels substantially below the cost to perform the procedure. As a result, many physicians, clinics and mobile services around the country are discontinuing this critical health service -- greatly reducing the public's access to the test and jeopardizing patients' quality of care.

This creates unnecessary barriers for those who cannot take the time for multiple healthcare provider visits and poses a serious threat to the frail and elderly who cannot travel long distances, particularly those living in rural areas. According to estimates, less than 14 percent of those who are eligible are being tested for osteoporosis; by passing this bill we can prevent this number from plunging even lower.

"In the U.S. today, one in two women and one in four men 50 and over will break a bone due to osteoporosis. We need Congress to pass this legislation in order to assure that access to testing is preserved and that those at risk of devastating and costly fractures are diagnosed and properly treated to prevent fractures," said Ethel Siris, M.D., president of th
'/>"/>

SOURCE National Osteoporosis Foundation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. Physician Skin Care Specialist Says Proposed New Rules for Sunscreen Products Will Better Protect the Public
3. More than 10,000 Medicare Patients in Montana Could Be Hit by Proposed Cuts to Home Oxygen Therapy; Access to Power Wheelchairs Would Also Decrease
4. Paramount Acquisition Corp. Announces Record Date of October 1, 2007 for Proposed Acquisition of Chem Rx
5. Kyphon Announces Special Meeting Date to Vote on Proposed Medtronic Merger
6. Hologic Sets Special Meeting of Stockholders to Vote on Proposed Merger with Cytyc Corporation
7. Microtek Medical Receives Early Termination of Hart-Scott-Rodino Act Waiting Period for Its Proposed Acquisition by Ecolab
8. Screening Proposed for Childhood Cholesterol Levels
9. Pelosi Statement on Proposed Entitlement Task Force
10. Paramount Acquisition Corp. Files Amendment to Preliminary Proxy Statement for Proposed Acquisition of Chem Rx
11. AARP Calls on State Regulators to Reject Proposed Settlement of TXU Buyout
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Ortho Organizers(R) Introduces Product Line Extension - Rectangular Super Elastic Nitanium(R) Black Ti(TM) Archwire 2Health News:Catalyst Pharmaceutical Partners Announces Positive Phase II Trial Results for Vigabatrin in the Treatment of Cocaine Addiction 2Health News:Catalyst Pharmaceutical Partners Announces Positive Phase II Trial Results for Vigabatrin in the Treatment of Cocaine Addiction 3Health News:Catalyst Pharmaceutical Partners Announces Positive Phase II Trial Results for Vigabatrin in the Treatment of Cocaine Addiction 4Health News:Catalyst Pharmaceutical Partners Announces Positive Phase II Trial Results for Vigabatrin in the Treatment of Cocaine Addiction 5Health News:Most ancient case of tuberculosis found in 500,000-year-old human; points to modern health issues 2Health News:AMAS Test Measures Lethal Replikin Gene Activity in Lung and Other Cancers 2Health News:AMAS Test Measures Lethal Replikin Gene Activity in Lung and Other Cancers 3Health News:Dr. William McGuire Settles with the SEC and the UnitedHealth Group Special Litigation Committee on Stock Options Matter 2Health News:Dr. William McGuire Settles with the SEC and the UnitedHealth Group Special Litigation Committee on Stock Options Matter 3Health News:Green Tea, Fruit Extracts Touted as Potential Cancer Fighters 2Health News:Green Tea, Fruit Extracts Touted as Potential Cancer Fighters 3
Breaking Medicine Technology:Lentigen Awarded Phase I SBIR Grant for Hepatitis C Vaccine 2Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix 2Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 4Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 5Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 6North Carolina Should Increase Cigarette Tax by 50 Cents to Save Lives and Raise Revenue 51095 1North Carolina Should Increase Cigarette Tax by 50 Cents to Save Lives and Raise Revenue 51095 2North Carolina Should Increase Cigarette Tax by 50 Cents to Save Lives and Raise Revenue 51095 3Genetic Breakthrough Spells Hope for Lung Fibrosis Patients 51092 1Genetic Breakthrough Spells Hope for Lung Fibrosis Patients 51092 2Intellikine Completes 2451 Million Financing 12939 1Intellikine Completes 2451 Million Financing 12939 2